Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
Aseem Anand*, Michael J. Morris, Steven M Larson, David Minarik, Andreas Josefsson, John T. Helgstrand, Peter S. Oturai, Lars Edenbrandt, Martin Andreas Røder, Anders Bjartell
Dive into the research topics of 'Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide'. Together they form a unique fingerprint.